Insulin resistance in patients with polycystic ovary syndrome

被引:40
|
作者
Schröder, AK
Tauchert, S
Ortmann, O
Diedrich, K
Weiss, JM
机构
[1] Unv Schleswig Holstein, Dept Obstet & Gynaecol, D-23538 Lubeck, Germany
[2] Univ Regensburg, Caritas Hosp St Josef, Dept Obstet & Gynaecol, D-8400 Regensburg, Germany
关键词
diabetes; insulin; insulin resistance; PCOS; polycystic ovary syndrome; review; risk;
D O I
10.1080/07853890410035296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With a prevalence of 5%-10% the polycystic ovary syndrome (PCOS) is an exceptionally common disorder of premenopausal women. According to prospective studies, women with PCOS present abnormal glucose tolerance and diabetes mellitus in 31%-35% and 7.5%-10%, respectively. PCOS patients have a higher prevalence of cardiovascular risk factors such as hypertension, type 2 diabetes and dyslipidaemia. The rate of spontaneous abortions as well as the risk to develop gestational or type 2 diabetes is increased in PCOS. Therefore, PCOS is not only a reproductive problem but a complex endocrine disease with important health implications. The role of the glucose metabolism in PCOS, the health consequences and possible interventions are reviewed in this article.
引用
收藏
页码:426 / 439
页数:14
相关论文
共 50 条
  • [31] Markers of insulin resistance and metabolic syndrome in polycystic ovary
    Trimeche, S.
    Safer, M. Abid
    Chaieb, M. Chadli
    Ajina, M. Zaouali
    Elghezal, R. Braham
    Beizig, A. Maaroufi
    Ach, K.
    Njah, M. Kacem
    Chaieb, L.
    [J]. DIABETES & METABOLISM, 2011, 37 : A70 - A70
  • [32] Current perspectives of insulin resistance and polycystic ovary syndrome
    Pauli, J. M.
    Raja-Khan, N.
    Wu, X.
    Legro, R. S.
    [J]. DIABETIC MEDICINE, 2011, 28 (12) : 1445 - 1454
  • [33] Limitations of insulin resistance assessment in polycystic ovary syndrome
    Lewandowski, Krzysztof C.
    Plusajska, Justyna
    Horzelski, Wojciech
    Bieniek, Ewa
    Lewinski, Andrzej
    [J]. ENDOCRINE CONNECTIONS, 2018, 7 (03): : 403 - 412
  • [34] Insulin resistance in polycystic ovary syndrome: Progress and paradoxes
    Venkatesan, AM
    Dunaif, A
    Corbould, A
    [J]. RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 : 295 - 308
  • [35] The role of miRNAs in polycystic ovary syndrome with insulin resistance
    Yingliu Luo
    Chenchen Cui
    Xiao Han
    Qian Wang
    Cuilian Zhang
    [J]. Journal of Assisted Reproduction and Genetics, 2021, 38 : 289 - 304
  • [36] Vascular insulin resistance in women with polycystic ovary syndrome
    Kelly, C
    Spiers, A
    Petrie, J
    Lyall, H
    Gould, G
    Connell, J
    [J]. JOURNAL OF HYPERTENSION, 2000, 18 : S8 - S8
  • [37] New markers of insulin resistance in polycystic ovary syndrome
    K. Polak
    A. Czyzyk
    T. Simoncini
    B. Meczekalski
    [J]. Journal of Endocrinological Investigation, 2017, 40 : 1 - 8
  • [38] Molecular mechanisms of insulin resistance in polycystic ovary syndrome
    Diamanti-Kandarakis, Evanthia
    Papavassiliou, Athanasios G.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2006, 12 (07) : 324 - 332
  • [39] EVIDENCE FOR INSULIN RESISTANCE IN POLYCYSTIC OVARY SYNDROME (PCO)
    LOBO, RA
    SHOUPE, D
    [J]. CLINICAL RESEARCH, 1983, 31 (01): : A57 - A57
  • [40] Prediction models for insulin resistance in the polycystic ovary syndrome
    Gennarelli, G
    Holte, J
    Berglund, L
    Berne, C
    Massobrio, M
    Lithell, H
    [J]. HUMAN REPRODUCTION, 2000, 15 (10) : 2098 - 2102